Pemphigus herpetiformis: Analysis of the autoantibody profile during the disease course with changes in the clinical phenotype: Clinical dermatology • Original article

Clinical and Experimental Dermatology

Volumn 35, Issue 4, 2010, Pages 366-372

  Lebeau, S ^a   Muller R ^b   Masouye I ^a   Hertl, M ^b   Borradori, L ^c  

^a UNIVERSITY HOSPITAL   (Switzerland)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENT COMPONENT C3; DAPSONE; DESMOGLEIN 1 ANTIBODY; DESMOGLEIN 3; DESMOGLEIN 3 ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G4 AUTOANTIBODY; PREDNISONE; UNCLASSIFIED DRUG;

ADULT; ANNULAR ERYTHEMA; ANTIBODY TITER; ARTICLE; CASE REPORT; DISEASE COURSE; DRUG DOSE INCREASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EROSION; FEMALE; HISTOLOGY; HUMAN; HYPERPIGMENTATION; IMMUNOBLOTTING; MOUTH INJURY; MOUTH LESION; PAPULOVESICULAR RASH; PEMPHIGUS; PEMPHIGUS HERPETIFORMIS; PHENOTYPE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; SKIN DEFECT; SKIN EDEMA; SKIN INFILTRATE;

ADULT; AGED; AUTOANTIBODIES; BIOPSY; DESMOGLEIN 3; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PEMPHIGUS; PHENOTYPE; SKIN; YOUNG ADULT;

EID: 77951241503     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2009.03525.x     Document Type: Article

References (28)

1. Green KJ, Gaudry CA. Are desmosomes more than tethers for intermediate filaments? Nat Rev Mol Cell Biol 2000 1 : 208 216.
2. Amagai M, Tsunoda K, Zillikens D et al. The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile. J Am Acad Dermatol 1999 40 : 167 170. (Pubitemid 29072792)
3. Yoshida K, Takae Y, Saito H et al. Cutaneous type pemphigus vulgaris: a rare clinical phenotype of pemphigus. J Am Acad Dermatol 2005 52 : 839 845. (Pubitemid 40614649)
4. Jablonska S, Chorzelski TP, Beutner EH, Chorzelska J. Herpetiform pemphigus, a variable pattern of pemphigus. Int J Dermatol 1975 14 : 353 359.
5. Ishii K, Amagai M, Komai A et al. Desmoglein 1 and desmoglein 3 are the target autoantigens in herpetiform pemphigus. Arch Dermatol 1999 135 : 943 947. (Pubitemid 29382431)
6. De Mente FJ, Grover RW. Acantholytic herpetiform dermatitis. Arch Dermatol 1973 107 : 883.
7. Seah PP, Fry L, Cairns RJ, Feiwel M. Pemphigus controlled by sulfapyridine. Br J Dermatol 1973 89 : 77.
8. Barrance VP. Mixed bullous disease. Arch Dermatol 1974 110 : 221.
9. Amagai M, Hashimoto T, Green KJ et al. Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. J Invest Dermatol 1995 104 : 895 901.
10. Mahoney MG, Wang Z, Rothenberger K et al. Explanations for the clinical and microscopic localization of lesions in pemphigus foliaceus and vulgaris. J Clin Invest 1999 103 : 461 468. (Pubitemid 29094045)
11. Sogai R, Kawada A, Aragane Y et al. A case of herpetiform pemphigus with anti-desmoglein 3 IgG autoantibodies. J Dermatol 2004 31 : 407 410. (Pubitemid 38855800)
12. Baykal C, Azizlerli G, Thoma-Uszynski S, Hertl M. Pemphigus vulgaris localized to the nose and cheeks. J Am Acad Dermatol 2002 47 : 875 880. (Pubitemid 35403046)
13. Müller E, Kernland K, Caldelari R et al. Unusual pemphigus phenotype in the presence of a Dsg1 and Dsg3 autoantibody profile. J Invest Dermatol 2002 118 : 551 555. (Pubitemid 34227178)
14. Beutner EH, Chorzelski TP, Jablonska S. Immunofluorescence tests. Clinical significance of sera and skin in bullous diseases. Int J Dermatol 1985 24 : 405 421. (Pubitemid 15246713)
15. Sitaru C, Mihai S, Zillikens D. The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases. Arch Dermatol Res 2007 299 : 1 8. (Pubitemid 46723573)
16. Kricheli D, David M, Frusic-Zlotkin M et al. The distribution of pemphigus vulgaris-IgG subclasses and their reactivity with desmoglein 3 and 1 in pemphigus patients and their first-degree relatives. Br J Dermatol 2000 143 : 337 342. (Pubitemid 30650402)
17. Spaeth S, Riechers R, Borradori L et al. IgG, IgA and IgE autoantibodies against the ectodomain of desmoglein 3 in active pemphigus vulgaris. Br J Dermatol 2001 144 : 1183 1188. (Pubitemid 34204209)
18. Müller R, Svoboda V, Wenzel E et al. IgG reactivity against non-conformational NH-terminal epitopes of the desmoglein 3 ectodomain relates to clinical activity and phenotype of pemphigus vulgaris. Exp Dermatol 2006 15 : 606 614. (Pubitemid 43983848)
19. Müller R, Svoboda V, Wenzel E et al. IgG against extracellular subdomains of desmooglein 3 relates to clinical phenotype of pemphigus vulgaris. Exp Dermatol 2008 17 : 35 43. (Pubitemid 350269210)
20. Sekiguchi M, Futei Y, Fujii Y et al. Dominant autoimmune epitopes recognized by pemphigus antibodies map to the N-terminal adhesive region of desmogleins. J Immunol 2001 167 : 5439 5448. (Pubitemid 33009785)
21. Amagai M, Karpati S, Prussick R et al. Autoantibodies against the amino-terminal cadherin-like binding domain of pemphigus vulgaris antigen are pathogenic. J Clin Invest 1992 90 : 919 926.
22. Tsunoda K, Ota T, Aoki M et al. Induction of pemphigus phenotype by a mouse monoclonal antibody against the amino-terminal adhesive interface of desmoglein 3. J Immunol 2003 170 : 2170 2178. (Pubitemid 36197441)
23. Kawasaki H, Tsunoda K, Hata T et al. Synergistic pathogenic effects of combined mouse monoclonal anti-desmoglein 3 IgG antibodies on pemphigus vulgaris blister formation. J Invest Dermatol 2006 126 : 2621 2630. (Pubitemid 44764046)
24. Sitaru C, Schmidt E, Petermann S et al. Autoantibodies to bullous pemphigoid antigen 180 induce dermal-epidermal separation in cryosections of human skin. J Invest Dermatol 2002 118 : 664 671. (Pubitemid 34309987)
25. Sitaru C, Kromminga A, Hashimoto T et al. Autoantibodies to type VII collagen mediate Fcgamma-dependent neutrophil activation and induce dermal-epidermal separation in cryosections of human skin. Am J Pathol 2002 161 : 301 311. (Pubitemid 34760796)
26. Kaneko M, Swanson MC, Gleich GJ, Kita H. Allergen-specific IgG1 and IgG3 through Fc gamma RII induce eosinophil degranulation. J Clin Invest 1995 95 : 2813 2821.
27. Grando SA, Pittelkow MR, Shultz LD et al. Pemphigus: an unfolding story. J Invest Dermatol 2001 117 : 990 995.
28. Evangelista F, Dasher DA, Diaz LA et al. E-cadherin is an additional immunological target for pemphigus autoantibodies. J Invest Dermatol 2008 128 : 1710 1718. (Pubitemid 351847386)